Thank you to Dr. Hal Dietz for a great Berne Lecture! Title: Leveraging Nature’s Success: Lessons from Modifiers of Marfan Syndrome and Related Aneurysm Conditions Topic: Dysregulation of TGFβ signaling has been implicated in many disease states including Marfan syndrome … Read More
School of Medicine researchers have identified a key contributor to high blood pressure that could lead to new treatments for a condition which affects almost half of American adults. The discovery from UVA’s Swapnil Sonkusare, PhD, and colleagues breaks new … Read More
A multidisciplinary team led by Jonathan Lindner, MD, the Frances Myers Ball Professor of Medicine and Vice-chief for Research in the Cardiology Division, was awarded a $3.5M R01 grant from the NIH to develop novel therapies for preventing aortic stenosis. … Read More
Cardiovascular Medicine Professor Kenneth Walsh, MD, PhD, and his team used cutting-edge CRISPR gene-editing technology to develop a special mouse model to better understand the effects of Y chromosome loss in the blood. They found that the loss accelerated age-related … Read More
University of Virginia School of Medicine scientists have identified a potential way to improve heart function after heart attacks – and it could involve a drug extracted from plants commonly used as folk medicine. The researchers, led by Dr. Matthew … Read More
The ASPET Division for Cardiovascular Pharmacology is pleased to award Dr. Swapnil Sonkusare from the University of Virginia the inaugural 2022 Division for Cardiovascular Pharmacology Mid-Career Award. This award recognizes and honors mid-career stage, independent investigators working in cardiovascular science. … Read More
Dr. Yen-Lin Chen wins American Physiological Society Cardiovascular Section Postdoctoral Scientist Award. Congratulations!!
Dr. Zdravka Daneva wins American Society for Pharmacology and Experimental Therapeutics Cardiovascular Pharmacology Postdoctoral Scientist Award. Congratulations!!
Wolf lab published a paper in Circulation Research, Inhibition of DYRK 1a Enhances Cardiomyocyte Cycling After Myocardial Infarction. Go here to view the here – ahajournals.org
Go here to view the recipients – SOM website
